medicine_id,formulation_id,version,component_1_id,component_1_name,component_1_type,component_1_qty,component_1_unit,component_2_id,component_2_name,component_2_type,component_2_qty,component_2_unit,component_3_id,component_3_name,component_3_type,component_3_qty,component_3_unit,component_4_id,component_4_name,component_4_type,component_4_qty,component_4_unit,manufacturing_process,mixing_time_minutes,compression_force_kn,coating_temperature_c,batch_size_standard,description,vector_note,created_at
MED-001,FORM-001,2.1,MAT-101,Amoxicillin Trihydrate,API,500,mg,MAT-201,Microcrystalline Cellulose,excipient,150,mg,MAT-202,Croscarmellose Sodium,excipient,30,mg,MAT-203,Magnesium Stearate,excipient,10,mg,"Dry mixing|Wet granulation|Drying at 60Â°C|Milling|Blending|Compression|Film coating",20,15,65,100000,Amoxicillin 500mg immediate release tablet formulation with standard excipients for antibiotic therapy,1536D vector field truncated - use OpenAI embedding,2024-01-10T08:30:00Z
MED-002,FORM-002,3.0,MAT-102,Metformin Hydrochloride,API,850,mg,MAT-201,Microcrystalline Cellulose,excipient,200,mg,MAT-204,Povidone K30,excipient,50,mg,MAT-203,Magnesium Stearate,excipient,15,mg,"API screening|Dry granulation|Milling|Blending|Compression|Film coating",25,18,70,150000,Metformin 850mg extended release tablet for type 2 diabetes management with controlled drug delivery,1536D vector field truncated - use OpenAI embedding,2024-02-15T10:00:00Z
MED-003,FORM-003,1.8,MAT-103,Ibuprofen,API,400,mg,MAT-201,Microcrystalline Cellulose,excipient,120,mg,MAT-202,Croscarmellose Sodium,excipient,25,mg,MAT-203,Magnesium Stearate,excipient,8,mg,"Dry mixing|Direct compression|Film coating",15,12,60,200000,Ibuprofen 400mg immediate release tablet for pain and inflammation management,1536D vector field truncated - use OpenAI embedding,2024-03-20T11:30:00Z
